Resistance to targeted therapy in renal-cell carcinoma - Abstract - UroToday PDF Print
UroToday... mammalian target of rapamycin (mtor), has produced robust clinical effects and revolutionised the treatment of metastatic renal-cell carcinoma (RCC).

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.

Notice: Undefined variable: query in /home/globaldi/public_html/components/com_joomlawatch/class.joomlawatch.db.php on line 129